Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02148003 · ClinicalTrials.gov registry record · NA
Effect of the Temperature Used in Thermal Radiofrequency Ablation
A NA study, sponsored by The Cleveland Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 199
- Enrollment target
NCT02148003 is a NA study that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 199 participants.
The verdict
NCT02148003, a NA study, was terminated before completion, sponsored by The Cleveland Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 199 participants
- Enrollment target
Study Summary
This study will determine if lumbar facets medial branches RFA at 90 degrees Celsius provides more overall pain relief (i.e., percent of improvement), when compared to ablation at 80 degrees Celsius with no additional adverse events.
Interventions
- PROCEDURE RFA at 90 degrees Celsius
- PROCEDURE RFA at 80 degrees Celsius
- DEVICE C-arm guided 20-gauge radiofrequency needle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 199 participants |
| Start Date | 2014-05 |
| Est. Completion | 2022-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02148003
The ClinicalTrials.gov registry entry for NCT02148003 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 199 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which RFA at 90 degrees Celsius is the first listed.
NCT02148003 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02148003 about?
NCT02148003 is a clinical study titled "Effect of the Temperature Used in Thermal Radiofrequency Ablation". This study will determine if lumbar facets medial branches RFA at 90 degrees Celsius provides more overall pain relief (i.e., percent of improvement), when compared to ablation at 80 degrees Celsius with no additional adverse events.
What is the current status of trial NCT02148003?
This trial is currently terminated. It is a NA study. The enrollment target is 199 participants. The study started on 2014-05. Estimated completion is 2022-09.
What interventions are being tested in trial NCT02148003?
The interventions under investigation include: RFA at 90 degrees Celsius (PROCEDURE), RFA at 80 degrees Celsius (PROCEDURE), C-arm guided 20-gauge radiofrequency needle (DEVICE).
Who is sponsoring clinical trial NCT02148003?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.